Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Study Shows Money CAN Buy Happiness

Study Shows Money CAN Buy Happiness

Van Leeuwen Release Ranch Flavored Ice Cream

Van Leeuwen Release Ranch Flavored Ice Cream

Yeti Recalls Nearly 2 Million Coolers

Yeti Recalls Nearly 2 Million Coolers

What Fed Rate Hikes Mean for You

Cheddar News Senior Reporter Chloe Aiello explains the trickle down effect the Fed rate hikes can have on the broader economy

Applications for US Jobless Aid Rise by Most in 5 Months

The number of Americans applying for unemployment benefits last week jumped by the most in five months, but layoffs remain historically low.

Peloton Imports Banned; Regulators Say Infringed on Dish Patents

Peloton Imports Banned; Regulators Say Infringed on Dish Patents

Cannabis Sales Decline as Economy Weakens

Cannabis Sales Decline as Economy Weakens

U.S. Chamber Of Commerce Pushes for A.I. Regulation

U.S. Chamber Of Commerce Pushes for A.I. Regulation

Bing AI Chat Reaches 100 Million Daily Active Users

Bing AI Chat Reaches 100 Million Daily Active Users

Trulieve to 'Lead From the Front' on Female Representation Amid Downward Trend in Cannabis

Trulieve CEO Kim Rivers is doubling down on creating a positive workplace for women — even as the percentage of women in executive positions in cannabis has stagnated in recent years.

Load More